Navigation Links
NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
Date:2/11/2010

and continuously removes excess fluid - known as ascites - that builds up in the abdominal cavity in patients with liver disease and other conditions.

"This is a milestone in our company history," said Noel Johnson, CEO and co-founder of NovaShunt, "and we strongly believe that this trial will both provide important clinical information and also demonstrate the benefit of continuous removal of ascites by the AFS-System in patients suffering from refractory ascites due to liver disease and other conditions."

Excess fluid build-up, which is known as ascites, in the abdominal cavity is a common complication among patients with late-stage liver disease, congestive heart failure (CHF) and certain cancers. Ascites affects more than a million patients in the EU and US. The majority of patients with ascites can be managed with a sodium-restricted diet and increasingly larger doses of diuretics. However, more than 10% of the patients develop refractory ascites and become non-responsive to diuretic therapy.

"Based on our pre-clinical research and our feasibility study results, the AFS System showed a significant reduction of paracentesis procedures and in the use of diuretics," said Dr. Pedro Eerdmans, Chief Medical Officer of the company. "We've seen some important clinical improvements in the feasibility study patients we enrolled in 2009. The AFS System decreased the overall need for paracentesis by more than 90% in our study group and one patient is fast approaching the one-year anniversary of his implant."

About the Automated Fluid Shunt (AFS) System

NovaShunt's innovative core technology is the Automated Fluid Shunt (AFS) System. The AFS System consists of a subcutaneously implanted battery-powered pump with a catheter placed in the abdominal cavity and another catheter connected to the bladder. The AFS System automatica
'/>"/>

SOURCE NovaShunt AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
2. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
3. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
4. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
5. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
6. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
7. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
10. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
11. BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... KING OF PRUSSIA, Pa. , Feb. 27, 2015 ... part of its ongoing commitment to the global bleeding ... it is donating 2 million international units (IUs) of ... WFH is an international not-for- profit organization which has ... and other inherited bleeding disorders. The donation supports the ...
(Date:2/27/2015)... TEL-AVIV, Israel , February 27, 2015 ... Unternehmen baut sein bahnbrechendes Überwachungssystem für kongestive ... weiter aus -   ... Medical Technologies, die ein neuartiges Herzüberwachungssystem für ... gab heute bekannt, dass sie ein Finanzierungsvorhaben ...
(Date:2/27/2015)... 2015  Two mass spectrometry technologies MALDI ... their effectiveness is established, according to biotechnology ... says that while mass spectrometry (mass spec ... in proteomic biomarker discovery and validation, mass ... techniques has struggled to elucidate molecular distribution ...
Breaking Medicine Technology:CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3
... Mich., Jan. 23, 2012  Researchers at the University of ... and found that less expensive, more effective tests are ... of patients receiving neuropathy diagnoses undergo high-cost, low-yield MRIs ... according to the study that will be published Jan. ...
... FALLS, N.Y., Jan. 23, 2012  Niagara Thermal Products LLC ... & Sons, Inc. The acquisition brings together two highly ... value custom thermal solutions in the aerospace, defense and ... ) "The addition of Kittredge,s industry recognized ...
Cached Medicine Technology:Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests 2Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests 3Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 2Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 3
(Date:2/28/2015)... February 28, 2015 The noted Friedman ... that they have officially relaunched their website. The new ... but it contains a new section about their team ... read the full biographies of each Friedman Dental Group ... the website was designed to provide our patients with ...
(Date:2/28/2015)... Javon Bea Mercy Health System CEO ... stroke capable by the State of Illinois, enabling potential ... Harvard Hospital. , The hospital was required to submit ... treat stroke according to national standards of care for ... to bypass hospitals not designated as an Emergent Stroke ...
(Date:2/28/2015)... Memphis, TN: MedixSafe has retracted a previous ... security reader named Guardian 2. The correct product ... biometric scanner that significantly increases the complexity of ... biometric scanner provides fast and easy access for ... narcotics lockers with Vanguard technology tracks inventory ...
(Date:2/28/2015)... 28, 2015 1Heart Caregiver Services ... emerging brand at Houston Texas Franchise Expo South ... sending its executive delegates headed by Vice-President of ... and Training Randolph Clarito. , Franchise Expo South, ... last February 4-7 and featured Franchise brands of ...
(Date:2/27/2015)... 27, 2015 OnChip Devices , ... introduced miniature, wire bondable, silicon ESD (Electrostatic Discharge) protection ... The ESD88NP and ESD88PN ... sensitive LED and IC products. These Zeners exhibit ... All devices meet the requirements of IEC61000 and ...
Breaking Medicine News(10 mins):Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3
... a neurobiological side to it. A new study suggests ... ,David Erritzoe and his colleagues at Copenhagen University ... normal weight and 29 overweight people. They found that ... the neurotransmitter serotonin than those of normal weight, reported ...
... methods of treatment in Urogynaecology will be the focus ... on Urogynaecology and Reconstructive pelvic surgery, that begins here ... of a pelvic surgery, being conducted at Government Kasturba ... ,,Briefing reporters about the three-day conference, Dr ...
... emirate will start a health insurance policy next month which ... companies that fall under the Phase 1 category will be ... which will make the lowest paid the first to benefit ... of the General Authority for Health Services (GAHS) in Abu ...
... has come up in Kolkata to contain Diarrheal diseases in ... one of the best of its kind equipped with the ... Minister for Health & Family Welfare, Dr. Anbumani Ramadoss, will ... named the 'Diarrheal Research and Control Centre' (DRCC) in the ...
... to Dr. Alexis Carrel digestive wastes which become stagnant in our ... 1911 for his discovery that growing live tissue cells can be ... not removed for three days then the cells become weak and ... meal that one eats. ,Studies have shown that if ...
... NHS news it is said that the breast cancer drug Herceptin ... But this is not happy news to the grieving family of ... cancer. But NHS officials denied her the drug which led to ... ,By profession she was an advertising art director from Wimbledon, ...
Cached Medicine News:Health News:Health Minister Inaugurates Institute for Diarrhea Diseases 2
Auto Refkeratomoeter...
... Management System answers the day-to-day needs ... flexibility. From programming to data retrieval, ... management right where you want it. ... to help each patient become ambulatory ...
... can be customized with selectable performance parameters ... and therapies. The COLLEAGUE pumps allow ... used for both gravity and pump regulation, ... simple infusions to medication therapies requiring complex ...
ChildLab is a service of Children's Hospital, Columbus Ohio...
Medicine Products: